Table 1 Study sample details

From: Mass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderly

Parameter

Low Responders (LR)

High Responders (HR)

N (male/female)

7 (5/2)

7 (4/3)

Median age (range), yrs

72 (66–78)

70 (69–73)

Time of sampling after vaccination in days, median (range)

33 (18–90)

27 (19–41)

Comorbidities (no./total)

 Asthma

1/7

0/7

 Chronic lung disease

1/7

1/7

 Diabetes

0/7

1/7

 Myocardial Infarction

1/7

1/7

 Heart condition

0/7

1/7

 Stroke (anytime)

1/7

0/7

 Chronic liver disease

0/7

0/7

 Chronic kidney disease

0/7

0/7

 Neurological disease

0/7

0/7

 Cancer (previous and active)

0/7

2/7

 Immunosuppressiona

2/7

0/7

  1. aBased on questionnaire, any one or more of: (i) Organ transplant recipient, (ii) Having an immunodeficiency, and (iii) Using immunosuppressive medications.